
illudin S anticancer drugs tox
in- ¥1000
- CONCORTIS
- D1005
- 2025年07月16日
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
大量
- CAS号:
1149-99-1
illudins是菌菇类产生的倍半萜烯类抗肿瘤生长类家族,对慢性粒细胞白血病和其他癌症显示细胞毒性。通过与DNA相结合,阻断转录过程而造成DNA损伤。而illudins S是家族成员之一,研究中,使用人癌细胞模型,发现细胞持续性暴露在illudins S and M 中,处于6—100nm浓度时对人白细胞有细胞毒作用。细胞动力学研究显示,illudin S导致在细胞停止分化于细胞周期G1-S期,最大暴露时间为2h。
CAS号:1149-99-1
英文别名:Illudin S; 4-08-00-02824 (Beilstein Handbook Reference); BRN 2336420; CCRIS 3540; DR-15978; Illudine S; Lampterol; Lunamycin; NSC 400979; NSC 626369; 2',3'-Dihydro-2',6'-dihydroxy-2'-(hydroxymethyl)-2',4',6'-trimethylspiro(cyclopropane-1,5'-(5H)inden)-7'(6'H)-one; Spiro(cyclopropane-1,5'-(5H)inden)-7'(6'H)-one, 2',3'-dihydro-3',6'-dihydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-, (2'S-(2'alpha,3'beta,6'alpha))- (9CI); Sprio(cyclopropane-1,5'-(5H)inden)-7'(6'H)-one, 2',3'-dihydro-3',6'-dihydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-, (2'S,3'R,6'R)-; (2'S,3'R,6'R)-3',6'-dihydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-2',3'-dihydrospiro[cyclopropane-1,5'-inden]-7'(6'H)-one
分子式:C15H20O4
分子量:264.3169
InChI:InChI=1/C15H20O4/c1-8-10-9(6-13(2,7-16)12(10)18)11(17)14(3,19)15(8)4-5-15/h6,12,16,18-19H,4-5,7H2,1-3H3/t12-,13+,14+/m1/s1
密度: 1.34g/cm3
| 货号 | 产品名称 | 化学结构式 | 分子式 | 纯度 | 价格(US $) |
| D1005 | Illudin S | C15H20O4 M.t. 264.32 |
95% | Inquiry | |
参考文献:
1. Kelner, M. J., T. C. McMorris, et al. (1987). "Preclinical evaluation of illudins as anticancer agents." Cancer Res 47(12): 3186-3189.
2. Tanaka, K., T. Inoue, et al. (1996). "Michael-type addition of illudin S, a toxic substance from Lampteromyces japonicus, with cysteine and cysteine-containing peptides in vitro." Chem Pharm Bull (Tokyo) 44(2): 273-279.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Use of Early Sea Urchin Embryos in Anticancer Drug Testing
In vitro anticancer drug testing is routinely performed on cell lines established from various types of malignant tumors. The use of these cell models has proved effective in determining the worthiness of potential drugs for further testing
【资源】Pubmed上以proteome,proteomics,protein(s),peptide(s)为关键词进行杂志搜索,摘选的大部分蛋白质组学,肽组学杂志---有较大的价值
of proteomics 3.65 Title Abbreviation: Expert Rev Proteomics Title(s): Expert review of proteomics. Publication Date(s): Vol. 1, no. 1 (June 2004)- Frequency: Bimonthly Publisher: London : Future Drugs Ltd., [2004]- Other Title(s): Proteomics
【翻译】Development trends for monoclonal antibody cancer therapeutics
% and 5%, respectively). This is probably due, at least in part, to the lack of success with radiolabelled products in the 1980s and the timing of mAb production method development. Humanized and human anticancer mAbs did not enter the clinic in large numbers
技术资料暂无技术资料 索取技术资料









